Saba Javed/LinkedIn
Aug 10, 2026, 04:33
Saba Javed: Managing VTE in Cancer Patients With Thrombocytopenia
Saba Javed, Assistant Manager, Cystic Fibrosis Clinical Pharmacist and Pediatric Infectious Disease Clinical Pharmacist at The Indus Hospital, shared a post on LinkedIn:
“I am currently reviewing many PICU oncology patients who are being treated with TLS, some of whom are undiagnosed or battling cancer.
It is well-known that oncology patients often have neutropenia and low platelet counts. I am interested in understanding how to manage cases where they develop VTE.
I came across a very informative article that specifies platelet count thresholds for administering or withholding treatment, specifically concerning LMWH (Enoxaparin).
Sharing a quick chart to review.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience